These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2109 related items for PubMed ID: 25561343

  • 1. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G, Ianiro G, Cianci R, Bibbò S, Gasbarrini A, Currò D.
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [Abstract] [Full Text] [Related]

  • 2. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.
    Matijašić M, Meštrović T, Perić M, Čipčić Paljetak H, Panek M, Vranešić Bender D, Ljubas Kelečić D, Krznarić Ž, Verbanac D.
    Int J Mol Sci; 2016 Apr 19; 17(4):. PubMed ID: 27104515
    [Abstract] [Full Text] [Related]

  • 3. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA, Baffy N.
    Postgrad Med; 2017 Nov 19; 129(8):872-888. PubMed ID: 28936910
    [Abstract] [Full Text] [Related]

  • 4. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
    Serban DE.
    Nutr Clin Pract; 2015 Dec 19; 30(6):760-79. PubMed ID: 26452390
    [Abstract] [Full Text] [Related]

  • 5. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
    Distrutti E, Monaldi L, Ricci P, Fiorucci S.
    World J Gastroenterol; 2016 Feb 21; 22(7):2219-41. PubMed ID: 26900286
    [Abstract] [Full Text] [Related]

  • 6. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT, Kim DJ.
    Expert Rev Gastroenterol Hepatol; 2019 Mar 21; 13(3):193-204. PubMed ID: 30791767
    [Abstract] [Full Text] [Related]

  • 7. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A.
    Clin J Gastroenterol; 2018 Feb 21; 11(1):1-10. PubMed ID: 29285689
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood.
    Eindor-Abarbanel A, Healey GR, Jacobson K.
    Int J Mol Sci; 2021 Nov 19; 22(22):. PubMed ID: 34830388
    [Abstract] [Full Text] [Related]

  • 9. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease.
    Wasilewski A, Zielińska M, Storr M, Fichna J.
    Inflamm Bowel Dis; 2015 Jul 19; 21(7):1674-82. PubMed ID: 25822014
    [Abstract] [Full Text] [Related]

  • 10. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J, Gardlik R.
    World J Gastroenterol; 2015 Oct 28; 21(40):11321-30. PubMed ID: 26525290
    [Abstract] [Full Text] [Related]

  • 11. Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?
    Berg D, Clemente JC, Colombel JF.
    Expert Rev Gastroenterol Hepatol; 2015 Jun 28; 9(6):781-95. PubMed ID: 25665875
    [Abstract] [Full Text] [Related]

  • 12. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.
    Schulberg J, De Cruz P.
    Intern Med J; 2016 Mar 28; 46(3):266-73. PubMed ID: 26968595
    [Abstract] [Full Text] [Related]

  • 13. Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies.
    Quigley EM.
    Gastroenterol Clin North Am; 2011 Mar 28; 40(1):207-22. PubMed ID: 21333908
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ, Cai CW, Ran ZH.
    J Dig Dis; 2016 Dec 28; 17(12):800-810. PubMed ID: 27743467
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC, Gundamaraju R, Shinde T, Eri R.
    Benef Microbes; 2017 Apr 26; 8(2):179-192. PubMed ID: 28008784
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T, Kim YS, Choi CH, Sadowsky MJ, Unno T.
    J Microbiol; 2018 Mar 26; 56(3):189-198. PubMed ID: 29492876
    [Abstract] [Full Text] [Related]

  • 18. Gut microbiota and inflammatory bowel disease: so far so gut!
    Holleran G, Lopetuso LR, Ianiro G, Pecere S, Pizzoferrato M, Petito V, Graziani C, McNAMARA D, Gasbarrini A, Scaldaferri F.
    Minerva Gastroenterol Dietol; 2017 Dec 26; 63(4):373-384. PubMed ID: 28293937
    [Abstract] [Full Text] [Related]

  • 19. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome.
    König J, Brummer RJ.
    Benef Microbes; 2014 Sep 26; 5(3):247-61. PubMed ID: 24583610
    [Abstract] [Full Text] [Related]

  • 20. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
    Aggeletopoulou I, Konstantakis C, Assimakopoulos SF, Triantos C.
    Microb Pathog; 2019 Dec 26; 137():103774. PubMed ID: 31586663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 106.